(CB) Chubb - Ratings and Ratios

Exchange: NYSE • Country: Switzerland • Currency: USD • Type: Common Stock • ISIN: CH0044328745

Property, Liability, Auto, Crop, Life

CB EPS (Earnings per Share)

EPS (Earnings per Share) of CB over the last years for every Quarter: "2020-09": 2, "2020-12": 3.18, "2021-03": 2.52, "2021-06": 3.62, "2021-09": 2.64, "2021-12": 3.81, "2022-03": 3.82, "2022-06": 4.2, "2022-09": 3.17, "2022-12": 4.05, "2023-03": 4.41, "2023-06": 4.92, "2023-09": 4.95, "2023-12": 5.54, "2024-03": 5.41, "2024-06": 5.38, "2024-09": 5.7, "2024-12": 6.02, "2025-03": 3.68, "2025-06": 6.14, "2025-09": 6.99,

CB Revenue

Revenue of CB over the last years for every Quarter: 2020-09: 9488, 2020-12: 9898, 2021-03: 9975, 2021-06: 9679, 2021-09: 10821, 2021-12: 10480, 2022-03: 9551, 2022-06: 9916, 2022-09: 12082, 2022-12: 11500, 2023-03: 11147, 2023-06: 11828, 2023-09: 13921, 2023-12: 13237, 2024-03: 12905, 2024-06: 13932, 2024-09: 15102, 2024-12: 14180, 2025-03: 13480, 2025-06: 14898, 2025-09: 16139,
Risk via 10d forecast
Volatility 18.7%
Value at Risk 5%th 28.8%
Relative Tail Risk -6.59%
Reward TTM
Sharpe Ratio 0.17
Alpha -0.94
Character TTM
Hurst Exponent 0.444
Beta 0.265
Beta Downside 0.338
Drawdowns 3y
Max DD 19.26%
Mean DD 6.31%
Median DD 5.60%

Description: CB Chubb September 25, 2025

Chubb Limited (NYSE: CB) is a global insurer and reinsurer operating through six primary segments: North America Commercial P&C, North America Personal P&C, North America Agricultural, Overseas General Insurance, Global Reinsurance, and Life Insurance. These segments collectively deliver a broad suite of coverages ranging from commercial property and liability to personal lines such as homeowners, auto, and cyber, as well as specialty products like crop-hail and political-risk insurance.

The firm’s product portfolio spans traditional lines (property, general liability, workers’ compensation, commercial marine) and niche offerings (environmental liability, professional indemnity, aviation, surety, and recreational marine). In the personal-line space it provides homeowners, automobile, collector-car, valuable-article, travel, and cyber policies, while its life-insurance arm offers whole life, universal life, term, group employee benefits, and supplemental health products such as critical-illness and dementia coverage.

Chubb was incorporated in 1985, rebranded from ACE Limited in January 2016, and is headquartered in Zurich, Switzerland. The company trades under the ticker “CB” on the NYSE and is classified in the GICS sub-industry “Property & Casualty Insurance.”

**Key metrics (2023)**: combined ratio ≈ 93.5% (indicating underwriting profitability), net income ≈ $6.5 bn, return on equity ≈ 13.5%, and dividend yield ≈ 2.5% with a payout ratio of ~55%. **Sector drivers**: a hardening insurance market due to rising climate-related loss exposure and a shift to higher reinsurance pricing cycles; **economic backdrop**: the recent rise in interest rates has boosted investment income, partially offsetting underwriting volatility. **Assumption**: figures are drawn from Chubb’s FY 2023 Form 10-K; future performance will depend on catastrophe trends, regulatory capital requirements, and the trajectory of global interest rates.

For a deeper, data-rich analysis of Chubb’s valuation dynamics and scenario modeling, you might explore the company’s profile on ValueRay.

CB Stock Overview

Market Cap in USD 113,441m
Sub-Industry Property & Casualty Insurance
IPO / Inception 1993-03-24
Return 12m vs S&P 500 -8.95%
Analyst Rating 3.45 of 5

CB Dividends

Dividend Yield 1.27%
Yield on Cost 5y 2.69%
Yield CAGR 5y 3.82%
Payout Consistency 96.1%
Payout Ratio 16.5%

CB Growth Ratios

CAGR 3y 13.82%
CAGR/Max DD Calmar Ratio 0.72
CAGR/Mean DD Pain Ratio 2.19
Current Volume 1391.7k
Average Volume 1843.6k

Piotroski VR‑10 (Strict, 0-10) 5.0

Net Income (9.68b TTM) > 0 and > 6% of Revenue (6% = 3.52b TTM)
FCFTA 0.05 (>2.0%) and ΔFCFTA -0.98pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue 25.22% (prev 33.55%; Δ -8.33pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.05 (>3.0%) and CFO 13.32b > Net Income 9.68b (YES >=105%, WARN >=100%)
Net Debt (17.23b) to EBITDA (13.47b) ratio: 1.28 <= 3.0 (WARN <= 3.5)
Current Ratio 10.88 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (403.2m) change vs 12m ago -1.15% (target <= -2.0% for YES)
Gross Margin 28.46% (prev 45.57%; Δ -17.10pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 22.54% (prev 22.02%; Δ 0.52pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 17.50 (EBITDA TTM 13.47b / Interest Expense TTM 748.0m) >= 6 (WARN >= 3)

Altman Z'' 1.89

(A) 0.05 = (Total Current Assets 16.30b - Total Current Liabilities 1.50b) / Total Assets 270.21b
(B) 0.25 = Retained Earnings (Balance) 66.72b / Total Assets 270.21b
(C) 0.05 = EBIT TTM 13.09b / Avg Total Assets 260.38b
(D) 0.37 = Book Value of Equity 62.06b / Total Liabilities 167.70b
Total Rating: 1.89 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 83.31

1. Piotroski 5.0pt = 0.0
2. FCF Yield 14.56% = 5.0
3. FCF Margin 22.69% = 5.67
4. Debt/Equity 0.24 = 2.47
5. Debt/Ebitda 1.28 = 1.34
6. ROIC - WACC (= 6.66)% = 8.33
7. RoE 14.28% = 1.19
8. Rev. Trend 87.17% = 6.54
9. EPS Trend 55.32% = 2.77

What is the price of CB shares?

As of November 16, 2025, the stock is trading at USD 295.49 with a total of 1,391,705 shares traded.
Over the past week, the price has changed by +2.76%, over one month by +3.82%, over three months by +7.53% and over the past year by +4.36%.

Is Chubb a good stock to buy?

Yes, based on ValueRay´s Fundamental Analyses, Chubb (NYSE:CB) is currently (November 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 83.31 and therefor a positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CB is around 302.56 USD . This means that CB is currently overvalued and has a potential downside of 2.39%.

Is CB a buy, sell or hold?

Chubb has received a consensus analysts rating of 3.45. Therefor, it is recommend to hold CB.
  • Strong Buy: 4
  • Buy: 5
  • Hold: 10
  • Sell: 3
  • Strong Sell: 0

What are the forecasts/targets for the CB price?

Issuer Target Up/Down from current
Wallstreet Target Price 307.5 4.1%
Analysts Target Price 307.5 4.1%
ValueRay Target Price 330.4 11.8%

CB Fundamental Data Overview November 11, 2025

Market Cap USD = 113.44b (113.44b USD * 1.0 USD.USD)
P/E Trailing = 12.0506
P/E Forward = 10.6724
P/S = 1.9279
P/B = 1.6165
P/EG = 2.0523
Beta = 0.527
Revenue TTM = 58.70b USD
EBIT TTM = 13.09b USD
EBITDA TTM = 13.47b USD
Long Term Debt = 14.38b USD (from longTermDebt, last fiscal year)
Short Term Debt = 1.50b USD (from shortTermDebt, last quarter)
Debt = 17.23b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 17.23b USD (from netDebt column, last quarter)
Enterprise Value = 91.48b USD (113.44b + Debt 17.23b - CCE 39.19b)
Interest Coverage Ratio = 17.50 (Ebit TTM 13.09b / Interest Expense TTM 748.0m)
FCF Yield = 14.56% (FCF TTM 13.32b / Enterprise Value 91.48b)
FCF Margin = 22.69% (FCF TTM 13.32b / Revenue TTM 58.70b)
Net Margin = 16.48% (Net Income TTM 9.68b / Revenue TTM 58.70b)
Gross Margin = 28.46% ((Revenue TTM 58.70b - Cost of Revenue TTM 41.99b) / Revenue TTM)
Gross Margin QoQ = 31.18% (prev 30.12%)
Tobins Q-Ratio = 0.34 (Enterprise Value 91.48b / Total Assets 270.21b)
Interest Expense / Debt = 1.14% (Interest Expense 197.0m / Debt 17.23b)
Taxrate = 20.21% (787.0m / 3.89b)
NOPAT = 10.44b (EBIT 13.09b * (1 - 20.21%))
Current Ratio = 10.88 (Total Current Assets 16.30b / Total Current Liabilities 1.50b)
Debt / Equity = 0.24 (Debt 17.23b / totalStockholderEquity, last quarter 71.86b)
Debt / EBITDA = 1.28 (Net Debt 17.23b / EBITDA 13.47b)
Debt / FCF = 1.29 (Net Debt 17.23b / FCF TTM 13.32b)
Total Stockholder Equity = 67.75b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.58% (Net Income 9.68b / Total Assets 270.21b)
RoE = 14.28% (Net Income TTM 9.68b / Total Stockholder Equity 67.75b)
RoCE = 15.94% (EBIT 13.09b / Capital Employed (Equity 67.75b + L.T.Debt 14.38b))
RoIC = 12.85% (NOPAT 10.44b / Invested Capital 81.27b)
WACC = 6.19% (E(113.44b)/V(130.67b) * Re(6.99%) + D(17.23b)/V(130.67b) * Rd(1.14%) * (1-Tc(0.20)))
Discount Rate = 6.99% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -33.33 | Cagr: -0.92%
[DCF Debug] Terminal Value 79.22% ; FCFE base≈13.91b ; Y1≈14.86b ; Y5≈17.99b
Fair Price DCF = 799.1 (DCF Value 314.48b / Shares Outstanding 393.6m; 5y FCF grow 7.60% → 3.0% )
EPS Correlation: 55.32 | EPS CAGR: 21.95% | SUE: 3.56 | # QB: 5
Revenue Correlation: 87.17 | Revenue CAGR: 13.11% | SUE: 0.94 | # QB: 1

Additional Sources for CB Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle